Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5270397
Max Phase: Preclinical
Molecular Formula: C24H10Br2N2O4S
Molecular Weight: 582.23
Associated Items:
ID: ALA5270397
Max Phase: Preclinical
Molecular Formula: C24H10Br2N2O4S
Molecular Weight: 582.23
Associated Items:
Canonical SMILES: O=C1c2cccc3cccc(c23)C(=O)N1c1nc(-c2cc3cc(Br)cc(Br)c3oc2=O)cs1
Standard InChI: InChI=1S/C24H10Br2N2O4S/c25-13-7-12-8-16(23(31)32-20(12)17(26)9-13)18-10-33-24(27-18)28-21(29)14-5-1-3-11-4-2-6-15(19(11)14)22(28)30/h1-10H
Standard InChI Key: QBOLTPLAODZOPR-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 582.23 | Molecular Weight (Monoisotopic): 579.8728 | AlogP: 6.40 | #Rotatable Bonds: 2 |
Polar Surface Area: 80.48 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 0 |
#RO5 Violations: 2 | HBA (Lipinski): 6 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 6.31 | CX LogD: 6.31 |
Aromatic Rings: 5 | Heavy Atoms: 33 | QED Weighted: 0.18 | Np Likeness Score: -0.87 |
1. Tomczyk MD, Walczak KZ.. (2018) l,8-Naphthalimide based DNA intercalators and anticancer agents. A systematic review from 2007 to 2017., 159 [PMID:30312931] [10.1016/j.ejmech.2018.09.055] |
Source(1):